Biomedical Offshore Value Fund, Ltd. — Form D/A
Biomedical Offshore Value Fund, Ltd. of GRAND CAYMAN, E9, a pooled investment fund, filed a Form D amendment with the SEC on 2021-12-20. $33.4M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2021-12-20
- Form: D/A
- Accession: 0001312877-21-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Amount sold: $33.4M
- Investors: 27
- Date of first sale: 2011-09-30
- Security types: fund interests
- SEC file number: 021-333737
Issuer
- Name: Biomedical Offshore Value Fund, Ltd.
- CIK: 0001312877
- Entity type: Corporation
- Jurisdiction: CAYMAN ISLANDS
- Address: INTERTRUST CORP. SERVICES (CAYMAN) LTD., GRAND CAYMAN, E9, KY1-9005
- Phone: 203-971-3300
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Jeffrey Jay | Director | Greenwich, CT |
| Jeffrey Jay | Executive Officer | Greenwich, CT |
| Jeffrey Jay | Promoter | Greenwich, CT |
| Alan Kelly | Director | Grand Cayman, E9 |
| Charl Grobler | Director | George Town, Grand Cayman, E9 |
| -- Great Point Partners, LLC | Executive Officer | Greenwich, CT |
| -- Great Point Partners, LLC | Promoter | Greenwich, CT |
| Riyaz Nooruddin | Director | Grand Cayman, E9 |
| David Kroin | Executive Officer | Greenwich, CT |
Other filings by this issuer (7)
More